Evidence map›Paper›PMID 17726083›Full record

ArticleThe Journal of clinical endocrinology and metabolism2007

Body mass index predicts aldosterone production in normotensive adults on a high-salt diet.

Rhonda Bentley-Lewis, Gail K Adler, Todd Perlstein, Ellen W Seely, Paul N Hopkins, Gordon H Williams, Rajesh Garg

3 registry-linked trialsOpen access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical endocrinology and metabolism, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 124 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
124citing papers in PubMed, 2 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02380157 phase4completednot on this mapstarted 2015, after this paper: background citation

Oral Potassium Supplementation in Healthy Men - Interactions With the Renin-angiotensin-aldosterone System and the Sympathetic Nervous System

TypeinterventionalSponsorGlostrup University Hospital, CopenhagenRan2015 to 2016Enrolled25ConditionsBlood Pressure, HypertensionArmsKaleorid, 750mg (trade name), Potassium chloride (active substance), Placebo
NCT03683069 phase4completednot on this mapstarted 2019, after this paper: background citation

Hypertension and Striatin Gene Structure Related to Aldo Phenotype

TypeinterventionalSponsorBrigham and Women's HospitalRan2019 to 2024Enrolled90ConditionsHypertension, Genetics HypertensionArmsEplerenone vs Amlodipine
NCT05593055 phase4recruitingnot on this mapstarted 2023, after this paper: background citation

Mineralocorticoid Receptor, Coronary Microvascular Function, and Cardiac Efficiency in Hypertension

TypeinterventionalSponsorBrigham and Women's HospitalRan2023 to 2027Enrolled75ConditionsHypertension, Left Ventricular HypertrophyArmsEplerenone, Chlorthalidone, Potassium
3 · Its place in the literature

Who cites it

124 citing papers in PubMed, 2 syntheses or guidelines pooled it, 214 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Obesity and the diagnostic accuracy for primary aldosteronism.Journal of clinical hypertension (Greenwich, Conn.) · 2017
    Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Review

64 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Rhonda Bentley-LewisDivision of Endocrinology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, USA.
Gail K Adler
Todd Perlstein
Ellen W Seely
Paul N Hopkins
Gordon H Williams
Rajesh Garg
Harvard University · USBrigham and Women's Hospital · USUniversity of Utah · US

Funding

Zoledronic Acid in Treatment of Osteoporosis in PostmenoM01RR002635 · NCRR · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1985 to 2008
$48.4M
YOHIMBINE AS A MODEL OF ORTHOSTATIC INTOLERANCEM01RR000095 · NCRR · VANDERBILT UNIVERSITY · PI MAY, JAMES M. · 1985 to 2008
$38.3M
VIRAL DAMAGE TO BRAIN AND NEUROMUSCULAR SYSTEMM01RR000064 · NCRR · UNIVERSITY OF UTAH · PI LEPPERT, MARK · 1985 to 2008
$21.7M
TRAINING PROGRAM IN CARDIOVASCULAR RESEARCHT32HL007604 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI MARK W FEINBERG · 1985 to 2026
$19.0M
SCOR MOLECULAR GENETICS OF HYPERTENSIONP50HL055000 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SEELY, ELLEN W · 1996 to 2005
$13.5M
Renal blood flow, vascular stiffness, and the DASH dietK24DK063214 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI CONLIN, PAUL R · 2003 to 2012
$1.7M
VASCULAR DISEASE IN HBP--ANGII, PAI1, INSULIN AND GENESR01HL059424 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1998 to 2001
$966k
SCHOLARS IN CLINICAL SCIENCE PROGRAMK30RR022292 · NCRR · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI WILLIAMS, GORDON H · 2005 to 2007
$900k
Mechanisms Underlying Sodium Intake Mediated Vascular FunctionK23RR023333 · NCRR · MASSACHUSETTS GENERAL HOSPITAL · PI BENTLEY-LEWIS, RHONDA · 2007 to 2011
$813k
GENETICS OF HYPERTENSIONR01HL047651 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI WILLIAMS, GORDON H · 1992 to 1995
–
NCRR NIH HHS 5K30RR22292-9NCRR NIH HHS K23 RR023333NCRR NIH HHS K30 RR022292NCRR NIH HHS M01 RR000064NCRR NIH HHS M01 RR000095NCRR NIH HHS M01RR00064NCRR NIH HHS M01RR00095NCRR NIH HHS M01 RR002635NCRR NIH HHS M01RR02635NHLBI NIH HHS HL59424NHLBI NIH HHS P50 HL055000NHLBI NIH HHS P50HL055000NHLBI NIH HHS R01 HL047651NHLBI NIH HHS T32 HL007604NHLBI NIH HHS T32 HL07604NIDDK NIH HHS DK63214NIDDK NIH HHS K24 DK063214NIMHD NIH HHS L32 MD001077
6 · The paper itself

Abstract

contextThe mechanisms underlying obesity-mediated cardiovascular disease are not fully understood. Aldosterone and insulin resistance both are associated with obesity and cardiovascular disease.

objectivesThe objectives of this study were to test the hypotheses that aldosterone production is elevated and associated with insulin resistance in overweight adults on a high-sodium diet. PARTICIPANTS/

interventionsHealthy normotensive adults were categorized as lean body mass index (BMI) less than 25 kg/m(2) (n = 63) or overweight BMI 25 kg/m(2) or greater (n = 57). After 7 d of a high-sodium diet, participants fasted overnight and remained supine throughout hemodynamic and laboratory assessments and angiotensin II (AngII) stimulation.

resultsThe overweight group, compared with the lean group, had higher 24-h urinary aldosterone (9.0 +/- 0.8 vs. 6.6 +/- 0.5 microg per 24 h; P = 0.003) and higher AngII-stimulated serum aldosterone (11.4 +/- 1.0 vs. 9.0 +/- 0.6 ng/dl; P = 0.04). There were no differences in 24-h urinary cortisol or sodium or supine measurements of plasma renin activity, serum aldosterone, or serum potassium. The homeostasis model assessment of insulin resistance was predicted by urinary aldosterone excretion (r = 0.32, P = 0.03) and serum aldosterone response to AngII stimulation (r = 0.28, P = 0.02) independent of age and BMI.

conclusionUrinary aldosterone excretion and AngII-stimulated aldosterone are increased in overweight, compared with lean, normotensive adults. The correlation of these measures of aldosterone production with insulin resistance suggests a potential role for aldosterone in the pathophysiology of obesity-mediated insulin resistance.

Indexed as

Body Mass IndexAdultAldosteroneAngiotensin IIDietFemaleHumansHydrocortisoneInfusions, IntravenousInsulin ResistanceMaleMiddle AgedOverweightReninSodium, DietaryVasoconstrictor AgentsAldosteroneAngiotensin IIHydrocortisoneReninSodium, DietaryVasoconstrictor Agents

Identifiers

PMID17726083
PMCPMC4428584
OpenAlexW2052968067

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.